Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
umbilical cord tissue-derived mesenchymal stromal cells
- Development stage
- Unknown
- Lead developer
- Duke University
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous, Intramyocardial, Intrathecal, Intraarticular, Intradermal, Intracoronary
01
Overview
Umbilical cord tissue-derived mesenchymal stromal cells (hCT-MSCs) are an allogeneic cellular therapy product manufactured from digested umbilical cord tissue. These cells are expanded in culture and cryopreserved for therapeutic use. hCT-MSCs are characterized by their ability to secrete paracrine factors that modulate humoral and cell-mediated immune responses, including the inhibition of T-cell, B-cell, NK-cell, and microglial proliferation, as well as the reduction of pro-inflammatory cytokine production. They are being investigated for a variety of conditions, including cerebral palsy, where they may promote neuroprotection and endogenous brain repair, and knee osteoarthritis, where they aim to improve the joint environment by reducing inflammation and supporting chondrocyte health.
- Other names
- human umbilical cord tissue-derived mesenchymal stromal cellsallogeneic umbilical cord tissue-derived mesenchymal stromal cellsUC-MSCUCT-MSC
Beyond the preview
Go deeper on umbilical cord tissue-derived mesenchymal stromal cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on umbilical cord tissue-derived mesenchymal stromal cells.